Ranitidine Recall: Alternative Treatments for Heartburn

A Michigan Medicine gastroenterologist discusses the recent recall of ranitidine, or Zantac, and shares treatment options and tips for individuals living with heartburn.

5:00 AM

Author | Jina Sawani

 

Recently, the Food and Drug Administration requested a manufacturer's market withdrawal of ranitidine, or Zantac, which many individuals take to treat heartburn. This recall means that all ranitidine products have been removed from the market and will no longer be available for new or existing prescriptions or over-the-counter use.

The FDA found that the drug may contain a contaminant known as N-nitrosodimethylamine, or NDMA, that is associated with pancreatic cancer, posing risks to patients.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunesGoogle Play and Stitcher

Michigan Medicine's William Chey, M.D., a gastroenterologist and professor of medicine and nutrition sciences, is an expert when it comes to treating heartburn. In this video, he discusses the recent ranitidine recall and offers tips for treating the condition now that Zantac is no longer an option.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

 


More Articles About: Health Management Reflux or GERD Pharmacy Digestive (GI) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Heartburn image
Health Lab
Feeling the Burn? Advice on Handling Heartburn During the Holidays
Heartburn can appear as an unwanted holiday guest. Here, Dr. William Chey shares tips for managing heartburn during any season.
Illustration of doctor pictured outside a pill bottle that houses a bent-over figure with pills lying on the ground
Health Lab
It’s easier now to treat opioid addiction with medication -- but use has changed little
Buprenorphine prescribing for opioid addiction used to require a special waiver from the federal government, but a new study shows what happened in the first year after that requirement was lifted.
Pill capsule pushing through a paper with amoxicillin printed on it.
Health Lab
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Overuse of antibiotics can lead bacteria to evolve antimicrobial resistance, but Americans are still receiving the drugs for many conditions that they can’t treat.
Illustration of prescription bottle with a refill notice
Health Lab
In drive to deprescribe, heartburn drug study teaches key lessons
An effort to reduce use of PPI heartburn drugs in veterans because of overuse, cost and potential risks succeeded, but provides lessons about deprescribing efforts.
Researcher in white coat focuses gaze on microbes pictured in a twisting tube illustrating the gut
Health Lab
Fiber, genes and the gut microbiome: Study reveals possible triggers for inflammatory bowel disease
A new U-M study finds a complex interplay between diet, genes, and the gut microbiota that could explain why IBD develops.
Person's hand holding an aspirin tablet with a glass of water nearby
Health Lab
An aspirin a day? Some older adults who take it may be following outdated advice
Many people aged 50 to 80 who said they take aspirin multiple times a week may not need to do so and could be causing health risks, according to National Poll on Healthy Aging.